Ninety seven transplant recipients participated in a controlled, clinical trial measuring the graft-enhancing property of a human gamma globulin preparation. The latter was prepared from the blood of pregnant women (RPGG) and contained antibodies with specificities for HLA locus products. Data analysis indicated that RPGG treated recipients had enhanced survival rates of their grafts if they had received one or more blood transfusions prior to transplantation.
|Number of pages||5|
|Journal||Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|
|Publication status||Published - 1 Dec 1979|
ASJC Scopus subject areas